Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 5.


Din, Shahida, Kent, Alexandra, Pollok, Richard C, Meade, Susanna, Kennedy, Nicholas A, Arnott, Ian, Beattie, R Mark, Chua, Felix, Cooney, Rachel, Dart, Robin J
et al (show 24 more authors) (2020) Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. GUT, 69 (10). 1769 - 1777.


Kennedy, Nicholas A, Jones, Gareth-Rhys, Lamb, Christopher A, Appleby, Richard, Arnott, Ian, Beattie, R Mark, Bloom, Stuart, Brooks, Alenka J, Cooney, Rachel, Dart, Robin J
et al (show 26 more authors) (2020) British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. GUT, 69 (6). 984 - 990.


Nelson, Andrew ORCID: 0000-0001-6665-4929, Stewart, Christopher J ORCID: 0000-0002-6033-338X, Kennedy, Nicholas A ORCID: 0000-0003-4368-1961, Lodge, John K ORCID: 0000-0001-6014-4952, Tremelling, Mark, Probert, Chris S ORCID: 0000-0003-4550-0239, Parkes, Miles, Mansfield, John C, Smith, Darren L ORCID: 0000-0003-4925-467X, Hold, Georgina L ORCID: 0000-0001-7573-3397
et al (show 4 more authors) (2020) The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and Individuals Without Gastrointestinal Inflammation. Journal of Crohn's & colitis.


Kennedy, Nicholas A, Lamb, Christopher A, Berry, Susan H, Walker, Alan W, Mansfield, John, Parkes, Miles, Simpkins, Rachel, Tremelling, Mark, Nutland, Sarah, Parkhill, Julian
et al (show 4 more authors) (2018) The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease. INFLAMMATORY BOWEL DISEASES, 24 (3). 583 - 592.


Mowat, Craig, Arnott, Ian, Cahill, Aiden, Smith, Malcolm, Ahmad, Tariq, Subramanian, Sreedhar ORCID: 0000-0002-6483-1730, Travis, Simon, Morris, John, Hamlin, John, Dhar, Anjan
et al (show 34 more authors) (2016) Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 1 (4). 273 - 282.

This list was generated on Sat Apr 17 13:49:19 2021 BST.